In part 6, the conclusion of this Exclusive Interview, Dr. Scott Kahan talks with Diabetes in Control Associate Medical Editor Joy Pape during the AACE 2018 convention in Boston, MA about the stigma and impact of having excess weight.

Better glycemic control than conventional subcutaneous insulin therapy in patients with T2DM

Significantly lower annualized rates of documented symptomatic hypoglycemia than Gla-100

Increased risks of autism spectrum disorder in association with types 1, 2, gestational diabetes

In subgroup analyses, reduced incidence of cancer seen in participants aged younger than 65 years

The ADA Scientific sessions are underway in Orlando and Steve Freed and Joy Pape, along with our two interns Kaytie and Kennen, and guest Michele Laine, ARNP, CDE, are there to cover all the latest in diabetes, and interview the thought leaders on where diabetes care is and where it …

The different mechanisms of action of these two drugs make them an excellent combination in the treatment of patients with type 2 diabetes mellitus (T2DM).

Investigation into the effect of surgery, from mortality to length of hospital stay, on patients who have diabetes with consistently high blood glucose.

Mini-dose glucagon might be a better option for treating exercise-induced hypoglycemia than carbohydrate ingestion or insulin dose reduction.

Study reveals how implementing occupational therapy strategies can help patients achieve glycemic goals.